Your browser doesn't support javascript.
loading
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.
Lansigan, Frederick; Barak, Ian; Pitcher, Brandelyn; Jung, Sin-Ho; Cheson, Bruce D; Czuczman, Myron; Martin, Peter; Hsi, Eric; Schöder, Heiko; Smith, Scott; Bartlett, Nancy L; Leonard, John P; Blum, Kristie A.
Afiliação
  • Lansigan F; Dartmouth College, Norris Cotton Cancer Center, Lebanon, New Hampshire.
  • Barak I; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Pitcher B; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Jung SH; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Cheson BD; MedStar Georgetown University Hospital, Washington, District of Columbia.
  • Czuczman M; Celgene, Inc., Morristown, New Jersey.
  • Martin P; Weill Medical College of Cornell University, New York, New York.
  • Hsi E; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Schöder H; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Smith S; Alliance Protocol Office, University of Chicago, Chicago, Illinois.
  • Bartlett NL; Washington University School of Medicine, St. Louis, Missouri.
  • Leonard JP; Weill Medical College of Cornell University, New York, New York.
  • Blum KA; Emory University School of Medicine, Atlanta, Georgia.
Cancer Med ; 8(1): 165-173, 2019 01.
Article em En | MEDLINE | ID: mdl-30575311

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Anticorpos Monoclonais Humanizados / Rituximab / Lenalidomida / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Anticorpos Monoclonais Humanizados / Rituximab / Lenalidomida / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos